US Patent Issued to TMEM16A on April 22 for "Solid forms of n-tert-butyl-4[[2-(5-chloro-2-hydroxy-phenyl)acetylaminopyridine-2-carboxamide" (British Inventors)

ALEXANDRIA, Va., June 6 -- United States Patent no. 12,281,077, issued on April 22, was assigned to TMEM16A Ltd. (Great Britain).

"Solid forms of n-tert-butyl-4[[2-(5-chloro-2-hydroxy-phenyl)acetylaminopyridine-2-carboxamide" was invented by Stephen Collingwood (Brighton, Great Britain) and Robert Melling (Abingdon, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to novel forms of N-tert-Butyl-4-[[2-(5-chloro-2-hydroxy-phenyl)acetyl]amino]pyridine-2-carboxamide (Compound 1). In particular, the invention relates to the Form A and Form B crystalline polymorphs and the amorphous form."

The patent was filed on Jan. 24, 2022, under Application No. 17/582,539.

*For further info...